# Allyson Tighe

> Allyson Tighe is a Series B investor at Amplitude Venture Capital (Toronto) backing Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Amplitude Venture Capital](https://shizune.co/investors/profile/amplitude-venture-capital)
- Location: Toronto, Canada
- Total investments: 1
- Last investment: Sep 2023
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/allyson-tighe-06b83215

Allyson Tighe is a Series B investor at Amplitude Venture Capital in Toronto focused on Biotechnology. Allyson Tighe is the Co-founder and Investor of Amplitude Venture Capital & she attended Richard Ivey School of Business in 2011.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tentarix Biotherapeutics | Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies. | $35M | Series B | Sep 06, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [Samsara BioCapital](https://shizune.co/investors/profile/samsara-biocapital) — VC Fund, 2 deals together
- [Versant Ventures](https://shizune.co/investors/profile/versant-ventures) — VC Fund, 2 deals together
- [Gilead Sciences](https://shizune.co/investors/profile/gilead-sciences) — VC Fund, 1 deal together

## About Amplitude Venture Capital

VC Fund · Montréal, Canada

Amplitude Venture Capital deploys a growth model that has successfully been used to build Canadian companies with world-class management teams and scale companies to breakout potential. Since 2012 Amplitude's founding team has raised over $700 million of equity capital in private and public markets. Amplitude, with offices in Montreal,Toronto, and Vancouver, launched its first private capital fund in November 2019, a $200-million fund that applies a proven, evidence-based approach to investing in leading Canadian precision medicine companies.

3 contacts available at Amplitude Venture Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Michael Mee | Principal | https://shizune.co/investors/profile/michael-mee-2 |
| Allyson Tighe | Co-Founder & Investor | https://shizune.co/investors/profile/allyson-tighe |
| Jean-François Pariseau | Co-Founder and Partner | https://shizune.co/investors/profile/jean-franois-pariseau |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Allyson Tighe invest in?

Allyson Tighe invests primarily in Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Allyson Tighe last invest?

The most recent investment recorded for Allyson Tighe closed in Sep 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co